Table 2 Comparison of the clinical characteristics of the children with shock and the other critically ill patients who received postpyloric nutrition
Shock | Other patients | p | |
|---|---|---|---|
Number of patients | 65 | 461 | |
Age (months) (median, range) | 12 (0.7–264) | 5 (0.1–228) | .020 |
Weight (kg) (median, range) | 8.8 (2.5–70) | 5.3 (2.1–70) | .0001 |
Sex (male/female) | 44/21 (2.1/1) | 248/213 (1.1/1) | .045 |
Cardiac surgery | 44 (67.7%) | 330 (71.6%) | .559 |
Dopamine (median, range) | 62 (95.4%) 10 (3–50) | 307 (66.6%) 5 (0.5–20) | .0001 .0001 |
Adrenaline (median, range) | 49 (75.4%) 0.3 (0.02–5) | 71 (15.4%) 0.2 (0.04–0.3) | .0001 .001 |
Milrinone (median, range) | 45 (69.2%) 0.7 (0.4–0.8) | 206 (44.7%) 0.5 (0.5–1) | .0001 .246 |
Acute renal failure | 26 (40%) | 27 (5.9%) | .0001 |
Hepatic disturbances | 3 (4.8%) | 6 (1.3%) | .081 |
Nosocomial pneumonia | 9 (15.5%) | 38 (8.9%) | .152 |
Mortality | 18 (27.7%) | 32 (6.9%) | .0001 |
Midazolam (median, range) | 64 (98.5%) 7 (2–16) | 384 (83.3%) 4 (0.5–20) | .0001 .0001 |
Fentanyl (median, range) | 64 (98.5%) 6.5 (1–14) | 366 (79.4%) 4 (1–25) | .0001 .0001 |
Vecuronium (median, range) | 51 (78.5%) 0.1 (0.1–0.25) | 179 (38.8%) 0.1 (0.1–0.3) | .0001 .660 |